Latest News in the pharma Industry

All

Avastin as effective as Eylea for treating central retinal vein occlusion

Avastin as effective as Eylea for treating central retinal vein occlusion

12 May 2017

NIH-funded clinical trial shows use of either drug improved vision and had few side effects.

Read more 
Hikma receives CRL regarding its ANDA for generic Advair Diskus

Hikma receives CRL regarding its ANDA for generic Advair Diskus

11 May 2017

Company believes low likelihood of approval this year.

Read more 
Merck's Keytruda scores another FDA approval

Merck's Keytruda scores another FDA approval

11 May 2017

FDA approves Keytruda as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) irrespective of PD-L1 expression.

Read more 
Takeda terminates plans for Vaxem Hib launch in Japan

Takeda terminates plans for Vaxem Hib launch in Japan

11 May 2017

Discontinuation due to the vaccine supplier’s (GSK) decision to discontinue global production.

Read more 
New licensing program facilitates adoption of Tandem Mass Tag technology

New licensing program facilitates adoption of Tandem Mass Tag technology

10 May 2017

Thermo Fisher Scientific helps research service providers and their customers optimize protein identification and quantitation.

Read more 
Croda celebrates EXCiPACT Certification across all leading excipient sites

Croda celebrates EXCiPACT Certification across all leading excipient sites

10 May 2017

Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities.

Read more 
Gyros Protein Technologies introduces next generation Gyrolab Protein A Kit for biotherapeutics

Gyros Protein Technologies introduces next generation Gyrolab Protein A Kit for biotherapeutics

10 May 2017

Kit increases efficiency of residual protein A ligand detection.

Read more 
Roche's Tecentriq flops during Phase III trial

Roche's Tecentriq flops during Phase III trial

10 May 2017

IMvigor211 failed to meet its primary endpoint of overall survival (OS) compared with chemotherapy.

Read more 
CPhI Worldwide Advisory Board returns with five new global experts

CPhI Worldwide Advisory Board returns with five new global experts

9 May 2017

Board helps to steer the overall development of CPhI events and content.

Read more 
Optibrium and Goldfinch Bio sign agreement for StarDrop license

Optibrium and Goldfinch Bio sign agreement for StarDrop license

9 May 2017

Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery.

Read more 
Catalent provides commercial manufacturing of Lexicon Pharmaceuticals' orphan drug Xermelot following FDA approval

Catalent provides commercial manufacturing of Lexicon Pharmaceuticals' orphan drug Xermelot following FDA approval

9 May 2017

Xermelo is a first-in-class orally administered therapy for the treatment of carcinoid syndrome diarrhea.

Read more 
Bosch Packaging Technology presents Xelum platform for continuous manufacturing

Bosch Packaging Technology presents Xelum platform for continuous manufacturing

8 May 2017

Highly precise dosing of smallest amounts of API.

Read more